1 |
Frank LM, Enlow T, Holmes GL, Manasco P, Concannon S, Chen C et al. Lamictal(lamotrigine) monotherapy for typical absence seizures in children. Epilepsia 1999;40:973-9.
DOI
ScienceOn
|
2 |
Coppola G, Auricchio G, Federico R, Carotenuto M, Pascotto A. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures an openlabel, randomized, parallel-group study. Epilepsia 2004;45: 1049-53.
DOI
ScienceOn
|
3 |
Motte J, Trevathan E, Arvidsson JF, Barrera MN, Mullens EL, Manasco P. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox- Gastaut Study Group. N Engl J Med 1997;337:1807-12.
DOI
ScienceOn
|
4 |
Pina-Garza JE, Elterman RD, Ayala R, Corral M, Mikati MA, Pina-Garza MJ et al. Long-term tolerability and efficacy of lamotrigine in infants 1 to 24 months old. J Child Neurol 2008;23:853-61.
DOI
ScienceOn
|
5 |
Barron TF, Hunt SL, Hoban TF, Price ML. Lamotrigine monotherapy in children Pediatr Neurol 2000;23:160-3.
DOI
ScienceOn
|
6 |
Von Wegerer J, Hesslinger B, Berger M, Walden J. A calcium antagonistic effect of the new antiepileptic drug lamotrigine. Eur Neuropsychopharmacol 1997;7:77-81.
DOI
ScienceOn
|
7 |
Commission on classification and terminology of the International League Against Epilepsy. Proposal for revised clinical and electrographic classification of epileptic seizures. In: Wyllie E. editor. The treatment of epilepsy. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2001:291-7.
|
8 |
Timmings PL, Richens A. Lamotrigine as and add-on drug in the management of Lennox-Gastaut syndrome. Eur Neurol 1992;32:305-7.
DOI
ScienceOn
|
9 |
Shechter T, Shorter Z, Kramer U, Lerman-Sagie T, Ronen E, Rotem R et al. Adverse reaction of topiramate and lamotrigine in children. Pharmacoepidemiol Drug Saf 2005;14: 187-92.
DOI
ScienceOn
|
10 |
Cheung H, Kamp D, Harris E. An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 1992;13:107-12.
DOI
ScienceOn
|
11 |
Gamble CL, Williamson PR, Marson AG. Lamotrigine versus carbamazepine monotherapy for epilepsy. Cochrane Database of Systematic Reviews, Issue 3, 2009.
|
12 |
Duchowny M, Pellock JM, Graf WD, Billard C, Gilman J, Casale E et al. A placebo-controlled trials of lamotrigine add-on therapy for partial seizures in children. Neurology 1999;53:1724-31.
DOI
|
13 |
Xie X, Lancaster B, Peakman T, Garthwaite J. Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+channels and with native Na+channels in rat hippocampal neurons. Pflugers Arch 1995;430:437-46.
DOI
ScienceOn
|
14 |
Prasad A, Kuzniecky RI, Knowlton RC, Welty TE, Martin RC, Mendez M, et al. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy. Arch Neurol 2003;60:1100- 5.
DOI
ScienceOn
|
15 |
Peltola J, Peltola M, Auvinen A, Raitanen J, Fallah M, Keranen T. Retention rates of new antiepileptic drugs in localization- related epilepsy: a single center study. Acta Neurol Scand 2009;119:55-60.
DOI
ScienceOn
|
16 |
Mikati MA, Holmes GL. Lamotrigine in absence and primary generalized epilepsies. J Child Neurol 1997;12 Suppl 1: S29-37.
DOI
|
17 |
Barron TF, Hunt SL, Hoban TF, Price ML. Lamotrigine monotherapy in children. Pediatr Neurol 2000;23:160-3.
DOI
ScienceOn
|
18 |
Goa KL, Ross SR, Chrisp P. Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 1993;46:152-76.
|
19 |
Ignacio Valencia, Gerard Pinol-Ripoll, Divya S. Khurana, Huntley Hardison, Sanjeev V. Kothare, Joseph J.Melvin et al. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy. Eur J Paediatr Neurol 2009; 13:141-5.
DOI
ScienceOn
|
20 |
Messenheimer JA, Giorgi L, Risner ME. The tolerability of lamotrigine in children. Drug Saf 2001;22:303-12.
|
21 |
Smith SE. al-Zubaidy ZA, Chapman AG, Meldrum BS. Excitatory amino acid antagonists, lamotrigine and BW 1003C87 as anticonvulsants in the genetically epilepsy-prone rat. Epilepsy Research 1993;15:101-11.
DOI
ScienceOn
|
22 |
Pellock JM. The clinical efficacy of lamotrigine as an antiepileptic drug. Neurology 1994;44 Suppl 8:S29-35
|
23 |
Coppola G, Licciardi F, Sciscio N, Russo F, Carotenuto M, Pascotto A. Lamotrigine as first-line drug in childhood absence epilepsy: a clinical and neurophysiological study. Brain Dev 2004;26:26-9.
DOI
ScienceOn
|
24 |
Rambeck B, Wolf P. Lamotrigine clinical pharmacokinetics. Clinical Pharmacokinetics 1993;25:433-43.
DOI
ScienceOn
|
25 |
Duchowny M, Gilmaan J, Messenheimer J, Womble G, Risner M. Long-term tolerability and efficacy of lamotrigine in pediatric patients with epilepsy. J Child Neurol 2002;17: 278-85.
DOI
ScienceOn
|
26 |
Richens A, Yuen AW. Overview of the clinical efficacy of lamotrigine. Epilepsia 1991;32 Suppl 2:S13-6.
DOI
|
27 |
Buchanan N. The efficacy of lamotrigine on seizure control in 34 children, adolescent and young adults with intellectual and physical disability. Seizure 1995;4:223-6.
|